1. Anticancer Drug-Induced Cardiotoxicity: Insights and Pharmacogenetics.
- Author
-
Adhikari, Archana, Asdaq, Syed Mohammed Basheeruddin, Al Hawaj, Maitham A., Chakraborty, Manodeep, Thapa, Gayatri, Bhuyan, Nihar Ranjan, Imran, Mohd., Alshammari, Mohammed Kanan, Alshehri, Mohammed M., Harshan, Aishah Ali, Alanazi, Abeer, Alhazmi, Bushra Dhuhayyan, and Sreeharsha, Nagaraja
- Subjects
DRUG side effects ,PHARMACOGENOMICS ,CARDIOLOGICAL manifestations of general diseases ,HEART failure ,CARDIOVASCULAR diseases risk factors ,ARRHYTHMIA - Abstract
The advancement in therapy has provided a dramatic improvement in the rate of recovery among cancer patients. However, this improved survival is also associated with enhanced risks for cardiovascular manifestations, including hypertension, arrhythmias, and heart failure. The cardiotoxicity induced by chemotherapy is a life-threatening consequence that restricts the use of several chemotherapy drugs in clinical practice. This article addresses the prevalence of cardiotoxicity mediated by commonly used chemotherapeutic and immunotherapeutic agents. The role of susceptible genes and radiation therapy in the occurrence of cardiotoxicity is also reviewed. This review also emphasizes the protective role of antioxidants and future perspectives in anticancer drug-induced cardiotoxicities. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF